🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dolutegravir (DTG) and lamivudine (3TC) are indicated in combination with o...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05
Trial ID
NCT02738931
The purpose of this trial is to assess the non-inferior antiviral activity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-01
Trial ID
NCT01263015
The purpose of this trial is to assess the non-inferior antiviral activity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-19
Trial ID
NCT01227824
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-08-28
Trial ID
NCT03631732
Treatments Being Tested
Single-arm, single-center, Phase I/II clinical trial, in four groups. Indiv...
Status
Completed
Location
The Aurum Institute: Tembisa Clinical Research Centre
Start Date
2018-01-18
Trial ID
NCT03435146
Treatments Being Tested
This study will compare safety, efficacy, and tolerability of a two drug re...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-07-18
Trial ID
NCT02831764
Treatments Being Tested
First-line antiretroviral regimens are highly efficacious and generally wel...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-05-06
Trial ID
NCT03682848
Treatments Being Tested
Dolutegravir is a potent integrase strand transfer inhibitor. Abacavir/dolu...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-06
Trial ID
NCT03016533
Persistent HIV viremia occurs in most ART-treated patients and could arise ...
Status
Completed
Location
Liège university hospital
Start Date
2019-01-01
Trial ID
NCT05351684
Treatments Being Tested
Treatment of human immunodeficiency virus (HIV) infection requires daily or...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02
Trial ID
NCT02373930